Blue Water Vaccines, Inc. (BWV)
| Market Cap | 59.61M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.86M |
| Shares Out | 12.82M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,316,999 |
| Open | 4.95 |
| Previous Close | 4.83 |
| Day's Range | 4.51 - 5.25 |
| 52-Week Range | 3.26 - 90.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BWV
Blue Water Vaccines is a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Our versatile vaccine platform has unique molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. Our lead influenza (flu) vaccine program uses proprietary technology to identify specific epitopes, or proteins, with cross-reactive properties that enables the potential development of a universal flu vaccine. We ar...
Financial Performance
Financial StatementsNews
Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments
CINCINNATI, May 13, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), today announced its financial results for the first quarter ended March 31, 2022 ...
Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference
CINCINNATI, May 12, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address signif...
5 Stocks Halted In Wednesday's Session: Here's Why
A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bring...
Blue Water Vaccines Announces Expanded License Agreement with St. Jude Children's Research Hospital for Novel Bacteri...
CINCINNATI, May 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today announced...
Why Is Blue Water Vaccines (BWV) Stock Up Today?
Blue Water Vaccines turned heads as BWV stock shot up more than 90% with no apparent news. What's going on with BWV stock?
Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress ...
CINCINNATI, April 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today issued ...
Blue Water Vaccines Announces Closing of $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Proceeds To Fund Research and Development of BWV-101, BWV-102 and BWV-103 Proceeds To Fund Research and Development of BWV-101, BWV-102 and BWV-103
Blue Water Vaccines Announces $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Proceeds To Fund Research and Development of BWV-101, BWV 102 and BWV-103. Proceeds To Fund Research and Development of BWV-101, BWV 102 and BWV-103.
Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022
CINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address sign...
Blue Water Vaccines Announces Closing of Initial Public Offering
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing of ...
Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the pricing of...